Patents by Inventor Parinda A. MEHTA

Parinda A. MEHTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Precision Dosing Regimen
    Publication number: 20230165958
    Abstract: The disclosure is directed to precision dosing regimens to achieve a target concentration of alemtuzumab in a subject of between about 0.15 ?g/mL-about 0.6 ?g/mL at day 0, or the day of a transplantation event involving allogeneic hematopoietic cells. The disclosure is also directed to methods of increasing the percentage of a patient population having a concentration of alemtuzumab of between about 0.15 ?g/mL-about 0.6 ?g/mL at day 0.
    Type: Application
    Filed: April 27, 2021
    Publication date: June 1, 2023
    Applicant: CHILDREN'S HOSPITAL MEDICAL CENTER
    Inventors: Rebecca MARSH, Parinda A. MEHTA, Alexander A. VINKS
  • METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION
    Publication number: 20220205982
    Abstract: A method for determining a personalized full dose of a melphalan compound (e.g., melphalan) in a reduced intensity conditioning regimen (RIC) prior to hematopoietic cell transplantation for a subject based on pharmacokinetic features of the melphalan compound administered to the subject at a test dose.
    Type: Application
    Filed: May 15, 2020
    Publication date: June 30, 2022
    Applicant: CHILDREN'S HOSPITAL MEDICAL CENTER
    Inventors: Parinda MEHTA, Kenneth D.R. SETCHELL, Alexander A. VINKS